Mohammad Sholeh
Impact in
- Molecular Medicine top 2%
- Antibiotic Resistance in Bacteria
-
- Antibiotic Use and Resistance
Papers in
-
- Clostridium difficile and Clostridium perfringens research 5
- Tuberculosis Research and Epidemiology 5
- Antimicrobial Resistance in Staphylococcus 5
- Epidemiology 15
- Burkholderia infections and melioidosis 4
- Co-authors
- Ebrahim Kouhsari (17 shared papers)Marcela Krůtová (4 shared papers)Mehrdad Gholami (3 shared papers)Farajolah Maleki (3 shared papers)Sajad Yaghoubi (4 shared papers)Zahra Ghafouri (2 shared papers)Angelina Olegovna Zekiy (1 shared paper)Nourkhoda Sadeghifard (4 shared papers)
In The Last Decade
Mohammad Sholeh
46 papers receiving 671 citations
Hit Papers
Peers
Comparison fields: 5 of 90
- Molecular Medicine 240
- Applied Microbiology and Biotechnology 61
- Endocrinology 103
- Infectious Diseases 181
- Clinical Biochemistry 49
Countries citing papers authored by Mohammad Sholeh
This map shows the geographic impact of Mohammad Sholeh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mohammad Sholeh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mohammad Sholeh more than expected).
Fields of papers citing papers by Mohammad Sholeh
This network shows the impact of papers produced by Mohammad Sholeh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mohammad Sholeh. The network helps show where Mohammad Sholeh may publish in the future.
Co-authors
The 25 scholars most cited alongside Mohammad Sholeh, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 56 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Tigecycline antibacterial activity, clinical effectiveness, and mechanisms and epidemiology of resistance: narrative review Hit paper breakdown → | 2021 | 192 |
| 2 | 2020 | 97 | |
| 3 | 2020 | 63 | |
| 4 | 2020 | 63 | |
| 5 | 2023 | 19 | |
| 6 | 2024 | 17 | |
| 7 | 2020 | 14 | |
| 8 | 2019 | 13 | |
| 9 | 2023 | 12 | |
| 10 | 2021 | 12 | |
| 11 | 2022 | 12 | |
| 12 | 2021 | 11 | |
| 13 | 2024 | 11 | |
| 14 | 2024 | 10 | |
| 15 | 2023 | 9 | |
| 16 | 2020 | 9 | |
| 17 | 2025 | 8 | |
| 18 | 2023 | 8 | |
| 19 | 2023 | 7 | |
| 20 | 2024 | 7 |
About Mohammad Sholeh
Mohammad Sholeh is a scholar working on Infectious Diseases, Epidemiology, Molecular Medicine, Molecular Biology and Endocrinology, having authored 56 papers that have together received 679 indexed citations. Recurring topics across this work include Antibiotic Resistance in Bacteria (13 papers), Antibiotic Use and Resistance (6 papers), Clostridium difficile and Clostridium perfringens research (5 papers), Tuberculosis Research and Epidemiology (5 papers), Antimicrobial Resistance in Staphylococcus (5 papers), Brucella: diagnosis, epidemiology, treatment (5 papers), Helicobacter pylori-related gastroenterology studies (4 papers) and Burkholderia infections and melioidosis (4 papers). The work is most often cited by research in Molecular Medicine (240 citations), Applied Microbiology and Biotechnology (61 citations), Endocrinology (103 citations), Infectious Diseases (181 citations) and Clinical Biochemistry (49 citations). Mohammad Sholeh has collaborated with scholars based in Iran, Czechia and China. Frequent co-authors include Ebrahim Kouhsari, Marcela Krůtová, Mehrdad Gholami, Farajolah Maleki, Sajad Yaghoubi, Zahra Ghafouri, Angelina Olegovna Zekiy, Nourkhoda Sadeghifard, Abbas Maleki and Payam Behzadi. Their work appears in journals such as Frontiers in Pharmacology, PLoS ONE, PLoS neglected tropical diseases, Apmis and Frontiers in Cellular and Infection Microbiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.